Cha Myoungil 4
4 · TANDEM DIABETES CARE INC · Filed Jun 20, 2024
Insider Transaction Report
Form 4
Cha Myoungil
Director
Transactions
- Exercise/Conversion
Common Stock
2024-06-17$45.33/sh+1,749$79,282→ 7,563 total - Exercise/Conversion
Restricted Stock Unit
2024-06-17−1,749→ 1,749 total→ Common Stock (1,749 underlying)
Footnotes (3)
- [F1]Awarded on June 15, 2022 pursuant to the Tandem Diabetes Care, Inc. 2013 Stock Incentive Plan, as amended, and the agreements related thereto (the 2013 Plan).
- [F2]Each restricted stock unit (RSU) represents a contingent right to receive either one share of common stock of the Issuer or cash in lieu thereof, at the Issuer's discretion, in accordance with the terms of the 2013 Plan.
- [F3]The total number of shares subject to the RSU will vest over a period of three years in equal annual installments on the anniversary of the grant, subject to the terms of the 2013 Plan.